ETHZilla (ATNFW) Stock Analysis

What ETHZilla does

180 Life Sciences Corp. is a biotechnology firm currently in the clinical trial phase, dedicated to pioneering novel pharmaceutical treatments that address significant unmet medical needs in areas such as inflammatory conditions, fibrotic disorders, and pain management. This research and development effort is powered by the collective expertise of distinguished therapeutics specialists from Oxford University, the Hebrew University, and Stanford University. The company was co-founded by Marc Feldmann, Lawrence J. Steinman, and Jonathan B. Rothbard on September 7, 2016, and maintains its principal office in Palo Alto, California.

Key metrics

ETFs linked to ATNFW

Broad-market and Healthcare sector ETFs an investor holding ETHZilla is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how ATNFW fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for ETHZilla?

ETHZilla trades under the ticker ATNFW on NASDAQ.

Which exchange is ATNFW listed on?

ATNFW is listed on NASDAQ.

What sector does ETHZilla operate in?

ETHZilla is classified in the Healthcare sector (Medical - Pharmaceuticals industry).

How can PortView help analyze ATNFW in a portfolio?

PortView shows ATNFW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.